<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33646079</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>10</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2325-6621</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Annals of the American Thoracic Society</Title><ISOAbbreviation>Ann Am Thorac Soc</ISOAbbreviation></Journal><ArticleTitle>Not Only about the Drugs: Improved Survival with Noninvasive Ventilation in Amyotrophic Lateral Sclerosis.</ArticleTitle><Pagination><StartPage>419</StartPage><EndPage>420</EndPage><MedlinePgn>419-420</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1513/AnnalsATS.202011-1404ED</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Berlowitz</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><Identifier Source="ORCID">0000-0003-2543-8722</Identifier><AffiliationInfo><Affiliation>Departments of Physiotherapy and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Breathing and Sleep, Heidelberg, Victoria, Australia; and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiratory and Sleep Medicine and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiotherapy, Austin Health, Heidelberg, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheers</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Medicine, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Breathing and Sleep, Heidelberg, Victoria, Australia; and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiratory and Sleep Medicine and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiotherapy, Austin Health, Heidelberg, Victoria, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Am Thorac Soc</MedlineTA><NlmUniqueID>101600811</NlmUniqueID><ISSNLinking>2325-6621</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004364">Pharmaceutical Preparations</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Ann Am Thorac Soc. 2021 Mar;18(3):486-494</RefSource><PMID Version="1">32946280</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063087" MajorTopicYN="Y">Noninvasive Ventilation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004364" MajorTopicYN="Y">Pharmaceutical Preparations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="Y">Respiratory Insufficiency</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>1</Day><Hour>12</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33646079</ArticleId><ArticleId IdType="pmc">PMC7919150</ArticleId><ArticleId IdType="doi">10.1513/AnnalsATS.202011-1404ED</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol. 2006;5:140&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pubmed">16426990</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackrivo J, Hsu JY, Hansen-Flaschen J, Elman L, Kawut SM. Non-invasive ventilation use is associated with better survival in amyotrophic lateral sclerosis. Ann Am Thorac Soc. 2021;18:486&#x2013;494.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7919153</ArticleId><ArticleId IdType="pubmed">32946280</ArticleId></ArticleIdList></Reference><Reference><Citation>Berlowitz DJ, Howard ME, Fiore JF, Jr, Vander Hoorn S, O&#x2019;Donoghue FJ, Westlake J, et al. Identifying who will benefit from non-invasive ventilation in amyotrophic lateral sclerosis/motor neurone disease in a clinical cohort. J Neurol Neurosurg Psychiatry. 2016;87:280&#x2013;286.</Citation><ArticleIdList><ArticleId IdType="pubmed">25857659</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo Coco D, Marchese S, Pesco MC, La Bella V, Piccoli F, Lo Coco A. Noninvasive positive-pressure ventilation in ALS: predictors of tolerance and survival. Neurology. 2006;67:761&#x2013;765.</Citation><ArticleIdList><ArticleId IdType="pubmed">16899545</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleopa KA, Sherman M, Neal B, Romano GJ, Heiman-Patterson T. Bipap improves survival and rate of pulmonary function decline in patients with ALS. J Neurol Sci. 1999;164:82&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">10385053</ArticleId></ArticleIdList></Reference><Reference><Citation>Aboussouan LS, Khan SU, Banerjee M, Arroliga AC, Mitsumoto H. Objective measures of the efficacy of noninvasive positive-pressure ventilation in amyotrophic lateral sclerosis. Muscle Nerve. 2001;24:403&#x2013;409.</Citation><ArticleIdList><ArticleId IdType="pubmed">11353427</ArticleId></ArticleIdList></Reference><Reference><Citation>Nickol AH, Hart N, Hopkinson NS, Moxham J, Simonds A, Polkey MI. Mechanisms of improvement of respiratory failure in patients with restrictive thoracic disease treated with non-invasive ventilation. Thorax. 2005;60:754&#x2013;760.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1747517</ArticleId><ArticleId IdType="pubmed">15939731</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannan LM, Rautela L, Berlowitz DJ, McDonald CF, Cori JM, Sheers N, et al. Randomised controlled trial of polysomnographic titration of noninvasive ventilation. Eur Respir J. 2019;53:1802118.</Citation><ArticleIdList><ArticleId IdType="pubmed">30880286</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, et al. EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS): revised report of an EFNS task force. Eur J Neurol. 2012;19:360&#x2013;375.</Citation><ArticleIdList><ArticleId IdType="pubmed">21914052</ArticleId></ArticleIdList></Reference><Reference><Citation>Morelot-Panzini C, Bruneteau G, Gonzalez-Bermejo J. NIV in amyotrophic lateral sclerosis: the &#x2018;when&#x2019; and &#x2018;how&#x2019; of the matter. Respirology. 2019;24:521&#x2013;530.</Citation><ArticleIdList><ArticleId IdType="pubmed">30912216</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavie L. Oxidative stress in obstructive sleep apnea and intermittent hypoxia: revisited. The bad ugly and good: implications to the heart and brain. Sleep Med Rev. 2015;20:27&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">25155182</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber SC, Mead RJ, Shaw PJ. Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. Biochim Biophys Acta. 2006;1762:1051&#x2013;1067.</Citation><ArticleIdList><ArticleId IdType="pubmed">16713195</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SM, Kim H, Lee JS, Park KS, Jeon GS, Shon J, et al. Intermittent hypoxia can aggravate motor neuronal loss and cognitive dysfunction in ALS mice. PLoS One. 2013;8:e81808.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3841127</ArticleId><ArticleId IdType="pubmed">24303073</ArticleId></ArticleIdList></Reference><Reference><Citation>Strickland LM, McCall AL, Pucci L, et al. Chronic intermittent hypoxia and hypercapnia induces respiratory insufficiency in an amyotrophic lateral sclerosis mouse model. FASEB J. 2019;33:551.19.</Citation></Reference><Reference><Citation>Bensimon G, Lacomblez L, Meininger V. ALS/Riluzole Study Group. A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med. 1994;330:585&#x2013;591.</Citation><ArticleIdList><ArticleId IdType="pubmed">8302340</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang T, Al Khleifat A, Meurgey J-H, Jones A, Leigh PN, Bensimon G, et al. Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study. Lancet Neurol. 2018;17:416&#x2013;422.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5899963</ArticleId><ArticleId IdType="pubmed">29525492</ArticleId></ArticleIdList></Reference><Reference><Citation>van Eijk RPA, Kliest T, McDermott CJ, Roes KCB, Van Damme P, Chio A, et al. TRICALS: creating a highway toward a cure. Amyotroph Lateral Scler Frontotemporal Degener. [online ahead of print] 9 Jul 2020; DOI: 10.1080/21678421.2020.1788092.</Citation><ArticleIdList><ArticleId IdType="pubmed">32643415</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>